Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Aukrust

Showing results (91-100 of 191) with videos related to

Pageof 20
Sort By:
European Journal of Clinical Investigation|November 30, 2005
Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infectionL Heggelund, T E Mollnes, T Espevik, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?T Wethal, H S Haugnes, J Kjekshus, et al.
Journal of Molecular and Cellular Cardiology|August 24, 2006
Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factorG Florholmen, B Halvorsen, K Beraki, et al.
The Journal of Infectious Diseases|October 23, 1997
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infectionP Aukrust, K Hestdal, E Lien, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 10, 1998
Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patientsE M Aandahl, P Aukrust, B S Skålhegg, et al.
Clinical and Experimental Immunology|February 17, 2007
Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivoB Fevang, A Yndestad, W J Sandberg, et al.
Blood|January 15, 1996
Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequencesP Aukrust, E Lien, A K Kristoffersen, et al.
The Journal of Nutrition|April 1, 1996
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense systemP M Ueland, M A Mansoor, A B Guttormsen, et al.
The Journal of Infectious Diseases|December 8, 1998
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failureP Aukrust, F Müller, E Lien, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapyS I Helle, T Ueland, D Ekse, et al.
Pageof 20

Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
European Journal of Clinical Investigation|November 30, 2005
Modulatory effect of mannose-binding lectin on cytokine responses: possible roles in HIV infectionL Heggelund, T E Mollnes, T Espevik, et al.
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?T Wethal, H S Haugnes, J Kjekshus, et al.
Journal of Molecular and Cellular Cardiology|August 24, 2006
Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factorG Florholmen, B Halvorsen, K Beraki, et al.
The Journal of Infectious Diseases|October 23, 1997
Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-alpha activity in human immunodeficiency virus type 1 infectionP Aukrust, K Hestdal, E Lien, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 10, 1998
Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patientsE M Aandahl, P Aukrust, B S Skålhegg, et al.
Clinical and Experimental Immunology|February 17, 2007
Low numbers of regulatory T cells in common variable immunodeficiency: association with chronic inflammation in vivoB Fevang, A Yndestad, W J Sandberg, et al.
Blood|January 15, 1996
Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency--possible immunologic and clinical consequencesP Aukrust, E Lien, A K Kristoffersen, et al.
The Journal of Nutrition|April 1, 1996
Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status--a possible element of the extracellular antioxidant defense systemP M Ueland, M A Mansoor, A B Guttormsen, et al.
The Journal of Infectious Diseases|December 8, 1998
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failureP Aukrust, F Müller, E Lien, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapyS I Helle, T Ueland, D Ekse, et al.
Pageof 20